ATE229518T1 - Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen - Google Patents
Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromenInfo
- Publication number
- ATE229518T1 ATE229518T1 AT97910264T AT97910264T ATE229518T1 AT E229518 T1 ATE229518 T1 AT E229518T1 AT 97910264 T AT97910264 T AT 97910264T AT 97910264 T AT97910264 T AT 97910264T AT E229518 T1 ATE229518 T1 AT E229518T1
- Authority
- AT
- Austria
- Prior art keywords
- syndromes
- prevention
- treatment
- related diseases
- estrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK119796 | 1996-10-28 | ||
PCT/DK1997/000483 WO1998018776A1 (en) | 1996-10-28 | 1997-10-28 | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE229518T1 true ATE229518T1 (de) | 2002-12-15 |
Family
ID=8102066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97910264T ATE229518T1 (de) | 1996-10-28 | 1997-10-28 | Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0937060B1 (de) |
JP (1) | JP2001502708A (de) |
AT (1) | ATE229518T1 (de) |
AU (1) | AU4772097A (de) |
CA (1) | CA2269974A1 (de) |
DE (1) | DE69717843T2 (de) |
DK (1) | DK0937060T3 (de) |
ES (1) | ES2188908T3 (de) |
IL (1) | IL129616A0 (de) |
NO (1) | NO992003L (de) |
WO (1) | WO1998018776A1 (de) |
ZA (1) | ZA979647B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19980064120A (ko) * | 1996-12-13 | 1998-10-07 | 김정규 | 신규한 벤조피란 유도체 |
WO2000039120A2 (en) * | 1998-12-30 | 2000-07-06 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
KR20010055766A (ko) * | 1999-12-13 | 2001-07-04 | 이경하 | 3-메틸-크로만 또는 티오크로만 유도체의 금속염 |
AU1888101A (en) * | 1999-12-13 | 2001-06-18 | Chugai Seiyaku Kabushiki Kaisha | 3-methyl-chroman and -thiochroman derivatives |
KR20010055765A (ko) * | 1999-12-13 | 2001-07-04 | 이경하 | 3-메틸-크로만 또는 티오크로만 유도체 |
EP2407462B1 (de) | 2004-09-21 | 2014-07-30 | Marshall Edwards, Inc. | Substituierte Chromanderivate, Medikamente und therapeutische Verwendung |
ES2377073T3 (es) * | 2004-09-21 | 2012-03-22 | Marshall Edwards, Inc. | Derivados de cromano sustituidos, medicamentos y utilización en terapia |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
MX2012014431A (es) | 2010-06-10 | 2013-02-26 | Aragon Pharmaceuticals Inc | Modulares del receptor de estrogenos y usos de los mismos. |
US9708283B2 (en) | 2010-11-01 | 2017-07-18 | Mei Pharma, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
WO2013090829A1 (en) * | 2011-12-14 | 2013-06-20 | Aragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
CA2974123C (en) | 2015-02-02 | 2023-08-01 | Mei Pharma, Inc. | Combination of benzopyran derivative and glycolytic inhibitors for cancer therapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
DE1543749A1 (de) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
-
1997
- 1997-10-28 AU AU47720/97A patent/AU4772097A/en not_active Abandoned
- 1997-10-28 ES ES97910264T patent/ES2188908T3/es not_active Expired - Lifetime
- 1997-10-28 DK DK97910264T patent/DK0937060T3/da active
- 1997-10-28 IL IL12961697A patent/IL129616A0/xx unknown
- 1997-10-28 ZA ZA9709647A patent/ZA979647B/xx unknown
- 1997-10-28 WO PCT/DK1997/000483 patent/WO1998018776A1/en active IP Right Grant
- 1997-10-28 JP JP10519942A patent/JP2001502708A/ja active Pending
- 1997-10-28 AT AT97910264T patent/ATE229518T1/de not_active IP Right Cessation
- 1997-10-28 CA CA002269974A patent/CA2269974A1/en not_active Abandoned
- 1997-10-28 DE DE69717843T patent/DE69717843T2/de not_active Expired - Fee Related
- 1997-10-28 EP EP97910264A patent/EP0937060B1/de not_active Expired - Lifetime
-
1999
- 1999-04-27 NO NO992003A patent/NO992003L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA979647B (en) | 1998-04-28 |
ES2188908T3 (es) | 2003-07-01 |
AU4772097A (en) | 1998-05-22 |
DK0937060T3 (da) | 2003-04-07 |
DE69717843T2 (de) | 2003-09-25 |
EP0937060A1 (de) | 1999-08-25 |
NO992003L (no) | 1999-06-25 |
EP0937060B1 (de) | 2002-12-11 |
JP2001502708A (ja) | 2001-02-27 |
IL129616A0 (en) | 2000-02-29 |
NO992003D0 (no) | 1999-04-27 |
CA2269974A1 (en) | 1998-05-07 |
DE69717843D1 (de) | 2003-01-23 |
WO1998018776A1 (en) | 1998-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RO115522B1 (ro) | Derivaţi de indolină, procedee pentru prepararea acestora, compoziţii farmaceutice care îi conţin şi metodă de tratament | |
ATE255589T1 (de) | Kristallin form i von clarithromycin | |
MY133647A (en) | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | |
FI20115753A (fi) | Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon | |
ES2130452T3 (es) | Derivados de ciclobutano utilizados como inhibidores de la escualeno-sintetasa y de la farnesiltransferasa proteica. | |
DK1200412T3 (da) | Antiproliferative imidazolforbindelser | |
NO20006645D0 (no) | Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme | |
NO965516D0 (no) | Sterolderivater anvendt til regulering av meiose | |
ATE229518T1 (de) | Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen | |
UA35607C2 (uk) | Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання | |
GR1001597B (el) | Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών. | |
PT736029E (pt) | Sulfamatos de pseudofructopiranose anticonvulsivos | |
BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
ATE231141T1 (de) | (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen | |
ATE229519T1 (de) | Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromen | |
NO992010L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
RU94000064A (ru) | Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции | |
NO992008L (no) | Nye (+)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992009L (no) | Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992005L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
EP0386920A3 (de) | 2-Hydroxy-3-thienyloxypropylamin-Derivate | |
NO992002L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992004L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
HK1009334A1 (en) | New 17(3-imino-2-alkyl-propenyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same | |
DE69428127D1 (de) | Schädlingsbekämpfungsmittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0937060 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |